Skip to content
10-Q

Quarterly Report

Bio-Rad Laboratories, Inc. BIO BIO-B

0000012208-25-000052

← back to feed
Filed
Jul 31, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2025 · Jun 30, 2025 27.23M sh
Shares Diluted Q2 2025 · Jun 30, 2025 27.59M sh
Shares Diluted Q2 2025 · Jun 30, 2024 28.4M sh
Shares Diluted Q2 2025 · Jun 30, 2024 28.46M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $242.1M
Stock Repurchased restated Q2 2025 · Jun 30, 2024 $105.7M
Capex Q2 2025 · Jun 30, 2025 $80.1M
Capex restated Q2 2025 · Jun 30, 2024 $82.5M
Operating Cash Flow Q2 2025 · Jun 30, 2025 $246.4M
Operating Cash Flow restated Q2 2025 · Jun 30, 2024 $167.4M
Long Term Debt Q2 2025 · Jun 30, 2025 $1.2B
Long Term Debt Q2 2025 · Dec 31, 2024 $1.2B
Short Term Investments Q2 2025 · Jun 30, 2025 $1B
Short Term Investments Q2 2025 · Dec 31, 2024 $1.18B
Cash And Equivalents Q2 2025 · Jun 30, 2025 $369.3M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $488.1M
Cash And Equivalents restated Q2 2025 · Jun 30, 2024 $406.9M
Stockholders Equity Q2 2025 · Jun 30, 2025 $7.13B
Stockholders Equity Q2 2025 · Mar 31, 2025 $6.68B
Stockholders Equity Q2 2025 · Dec 31, 2024 $6.57B
Stockholders Equity restated Q2 2025 · Jun 30, 2024 $6.78B
Stockholders Equity restated Q2 2025 · Mar 31, 2024 $9.05B
Stockholders Equity restated Q2 2025 · Dec 31, 2023 $8.74B
Current Liabilities Q2 2025 · Jun 30, 2025 $548.9M
Current Liabilities Q2 2025 · Dec 31, 2024 $467.8M
Total Liabilities Q2 2025 · Jun 30, 2025 $3.09B
Total Liabilities Q2 2025 · Dec 31, 2024 $2.79B
Current Assets Q2 2025 · Jun 30, 2025 $2.81B
Current Assets Q2 2025 · Dec 31, 2024 $3.03B
Total Assets Q2 2025 · Jun 30, 2025 $10.21B
Total Assets Q2 2025 · Dec 31, 2024 $9.36B
Eps Diluted Q2 2025 · Jun 30, 2025 $11.67
Eps Diluted Q2 2025 · Jun 30, 2025 $13.84
Eps Diluted Q2 2025 · Jun 30, 2024 −$76.26
Eps Diluted Q2 2025 · Jun 30, 2024 −$62.61
Eps Basic Q2 2025 · Jun 30, 2025 $11.67
Eps Basic Q2 2025 · Jun 30, 2025 $13.84
Eps Basic Q2 2025 · Jun 30, 2024 −$76.26
Eps Basic Q2 2025 · Jun 30, 2024 −$62.61
Sga Expense Q2 2025 · Jun 30, 2025 $207.7M
Sga Expense Q2 2025 · Jun 30, 2025 $416.5M
Sga Expense restated Q2 2025 · Jun 30, 2024 $194.7M
Sga Expense restated Q2 2025 · Jun 30, 2024 $409.6M
Rd Expense Q2 2025 · Jun 30, 2025 $60.5M
Rd Expense Q2 2025 · Jun 30, 2025 $134M
Rd Expense restated Q2 2025 · Jun 30, 2024 $58.9M
Rd Expense restated Q2 2025 · Jun 30, 2024 $125.3M
Net Income Q2 2025 · Jun 30, 2025 $317.8M
Net Income Q2 2025 · Jun 30, 2025 $381.8M
Net Income Q2 2025 · Mar 31, 2025 $64M
Net Income restated Q2 2025 · Jun 30, 2024 −$2.17B
Net Income restated Q2 2025 · Jun 30, 2024 −$1.78B
Net Income restated Q2 2025 · Mar 31, 2024 $383.9M
Operating Income Q2 2025 · Jun 30, 2025 $77.1M
Operating Income Q2 2025 · Jun 30, 2025 $100.8M
Operating Income restated Q2 2025 · Jun 30, 2024 $101.5M
Operating Income restated Q2 2025 · Jun 30, 2024 $146.2M
Gross Profit Q2 2025 · Jun 30, 2025 $345.3M
Gross Profit Q2 2025 · Jun 30, 2025 $651.3M
Gross Profit restated Q2 2025 · Jun 30, 2024 $355.1M
Gross Profit restated Q2 2025 · Jun 30, 2024 $681.1M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $306.3M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $585.7M
Cost Of Revenue restated Q2 2025 · Jun 30, 2024 $283.4M
Cost Of Revenue restated Q2 2025 · Jun 30, 2024 $568.2M
Revenue Q2 2025 · Jun 30, 2025 $651.6M
Revenue Q2 2025 · Jun 30, 2025 $1.24B
Revenue restated Q2 2025 · Jun 30, 2024 $638.5M
Revenue restated Q2 2025 · Jun 30, 2024 $1.25B